For every U.S. IPO worth covering, a Bellipo analyst dissects the full S-1 — business model, unit economics, capital structure, syndicate, comparable transactions, and disclosed risk factors — and rewrites it as a single, cited briefing. Free to read.
Late-stage private companies we're tracking before the S-1 lands.
Not filed with the SEC. Not a prediction, recommendation, or valuation. Each card links to a cited RADAR dossier — every figure with a source [n].
Artificial Intelligence
RADAR · Pre-filingSourcing
Public reporting only. Draft S-1 is confidential (not on EDGAR); every figure is third-party or company-confirmed.
Read the dossier →Financial Technology
RADAR · Pre-filingSourcing
Public reporting only. No S-1, no confirmed filing. Every figure is third-party reported or company-attributed via reporter.
Read the dossier →Artificial Intelligence
RADAR · Pre-filingSourcing
Public reporting only. Draft S-1 is confidential (not on EDGAR); every figure is third-party or company-confirmed.
Read the dossier →Data & AI Infrastructure
RADAR · Pre-filingSourcing
Public reporting only. No draft or public S-1 on EDGAR under Databricks' CIK as of the draft date [7]; valuation talks and financial run-rates are third-party reported or company-confirmed.
Read the dossier →Autonomous Mobility
RADAR · Pre-filingSourcing
Public reporting and company announcements only. No draft or public S-1 on EDGAR under a Waymo central index key (CIK) as of the draft date [7]; Waymo's financials are consolidated inside Alphabet's Other Bets segment and are not separately disclosed [8].
Read the dossier →Social & Gaming
RADAR · Pre-filingSourcing
The IPO claim is single-outlet: Bloomberg, January 6, 2026, sourced to unnamed "people familiar" [1]; Reuters and everything after it are pickups of that one report [2]. Discord's EDGAR record under central index key (CIK) 0001763840 contains six Form D exempt-offering notices and nothing else [3]. The one dated valuation trail that is not press chatter comes from a public filer: Destiny Tech100 Inc. (DXYZ) marks its Discord position every quarter in its N-PORT filings [10].
Read the dossier →Bellipo IPO dossier for City Therapeutics, Inc. (CTY) — filing tracked from S-1 to first trade.
BDI 70 ACTIVE Score sealed after pricing Published · Oct 16, 2026 Read Dossier AMRO AMRO · trading · ORBIT · Materials & Mining Amaero Inc.Bellipo IPO dossier for Amaero Inc. (AMRO) — filing tracked from S-1 to first trade.
Published · Oct 15, 2026 BDI · CalibratingIAM IAM · trading · ORBIT · Healthcare & Bio Iambic TherapeuticsIambic (IAM) files to sell 9,375,000 shares on Nasdaq at $15.00–$17.00. Clinical-stage, no product revenue. Every figure read from the…
Published · Oct 14, 2026 BDI 64 ACTIVE Frozen at pricingOURA OURA · filed · RADAR · Consumer wearables Oura Inc.Oura postponed its Nasdaq IPO on Sep 29, 2026 (Business Wire). It had marketed 50M shares at $40–$44, 73% sold by existing holders…
Published · Sep 27, 2026 BDI 68 ACTIVE LiveBRVE BRVE · trading · ORBIT · Clinical-Stage Biotechnology Braveheart Bio, Inc.Braveheart Bio IPO: 21,250,000 shares priced at $18.00 on Nasdaq, above the $15.00-$17.00 range. In-licensed lead candidate, trial…
Published · Aug 4, 2026 BDI 81 ELEVATED Frozen at pricingATTO ATTO · trading · ORBIT · Clinical-Stage Biotechnology Attovia Therapeutics, Inc.Attovia Therapeutics IPO: 17,000,000 shares at an expected $17.00 fixed price on Nasdaq. Clinical program, regulatory path, cash runway…
Published · Aug 4, 2026 BDI 80 ELEVATED Score sealed after pricingLTGO LTGO · trading · ORBIT · Clinical-Stage Biotechnology Latigo Biotherapeutics, Inc.Latigo Biotherapeutics IPO: 19,200,000 shares priced at $18.00 on Nasdaq Global Select, the top of the $16.00-$18.00 range. Two oral…
Published · Aug 4, 2026 BDI 78 ELEVATED Frozen at pricingVOGX VOGX · trading · ORBIT · Clinical-Stage Biotechnology Vogenx, Inc.Vogenx IPO: 6,250,000 shares at $11.00-$13.00 on Nasdaq Capital Market. Sole book-runner, going-concern paragraph, restatement, licensed…
Published · Aug 4, 2026 BDI 48 SUBDUED Computed from the recordBLSM BLSM · trading · ORBIT · Clinical-Stage Biotechnology BlossomHill Therapeutics, Inc.BlossomHill Therapeutics IPO: 9,375,000 shares priced at $16.00 on Nasdaq Global Select, within the $15.00-$17.00 range. Two clinical…
Published · Aug 4, 2026 BDI 70 ACTIVE Frozen at pricingSIND SIND · trading · ORBIT · Silver Exploration Sinda Ltd.Sinda Ltd. priced 17,750,000 shares at $12.00 on the NYSE. The full dossier: offering economics, the Fresnillo placement, the…
Published · Jul 30, 2026 BDI 62 ACTIVE Computed from the record Point-in-time inputs unavailable · upper boundAPMD APMD · trading · ORBIT · Clinical-Stage Biotechnology Apnimed, Inc.Bellipo's IPO dossier for Apnimed, Inc. (APMD) — filing tracked from S-1 to first trade.
Published · Jul 30, 2026 BDI 81 ELEVATED Frozen at pricingJMKE JMKE · trading · ORBIT · Restaurant Franchising Jersey Mike's Subs Inc.Jersey Mike's (JMKE) IPO dossier: priced at $23.00, 3,300 locations, $4.3B systemwide sales, NYSE listing, 33-bank syndicate — two-thirds…
Published · Jul 27, 2026 BDI 59 ACTIVE Computed from the recordREF REF · trading · ORBIT · Apparel & Fashion Retail Reformation Inc.Reformation (REF) IPO dossier: priced at $15.00, the low end of the band — 66 stores, ~90% direct-to-consumer revenue, NYSE listing…
Published · Jul 27, 2026 BDI 53 ACTIVE Frozen at pricingSTDN STDN · trading · ORBIT · Advanced Nuclear Fuel Standard Nuclear, Inc.Standard Nuclear lists on the NYSE: the only US industrial-scale TRISO fuel maker, first commercial delivery done, ~$125M cash, $245M…
Published · Jul 9, 2026 BDI 66 ACTIVE Score sealed after pricingCSQR CSQR · trading · ORBIT · Data Center Colocation Csquare, Inc.Csquare lists on the NYSE: 64 data centers, ~389 MW, ~$1.25B raise — but proceeds repay debt including a Brookfield note, with ~67%…
Published · Jul 9, 2026 BDI 45 SUBDUED Computed from the record Point-in-time inputs unavailable · upper boundTARX TARX · filed · RADAR · Clinical-Stage Biotechnology Tarsier Pharma Ltd.Tarsier Pharma lists on the NYSE: a steroid-free uveitis drug, a prior Phase 3 that missed, an FDA SPA-backed retry, going-concern flag…
Published · Jul 8, 2026 BDI 51 ACTIVE LiveSKHY SKHY · trading · ORBIT · Memory Semiconductors SK hynix Inc.SK hynix priced its Nasdaq ADS listing at $149 (424B4). First trade $168.31 (+12.96%), day-1 close $168.01 (+12.76%). Every number cited…
Published · Jul 7, 2026 BDI 77 ELEVATED Computed from the recordITG ITG · trading · ORBIT · Telecom & Utility Infrastructure Services ITG, Inc.ITG (ITG) IPO dossier: priced below range at $16 against a $19-22 book, 48% quarterly revenue growth, a $2.9B backlog, and rising debt…
Published · Jul 1, 2026 BDI 45 SUBDUED Frozen at pricing Methodology review pendingLIME LIME · trading · ORBIT · Shared Micromobility Neutron Holdings, Inc.Lime (LIME) IPO dossier: priced mid-range at $25 to raise ~$173.9M. The Uber-backed e-scooter and e-bike brand arrives public with fast…
Published · Jul 1, 2026 BDI 67 ACTIVE Frozen at pricingBSP BSP · trading · ORBIT · Consumer Software Bending Spoons S.p.A.Bending Spoons (BSP) IPO dossier: priced above range at $29 for ~$1.68B at a ~$20B valuation, with ~$4.36B of debt and ~83% founder…
Published · Jul 1, 2026 BDI 82 ELEVATED Frozen at pricingDPC DPC · trading · ORBIT · Aerospace & Defense DPC Holdings LtdDPC Holdings (Doncasters) is raising ~$700M in an all-primary NYSE IPO to pay down debt — record $930M backlog, 16.5% margins, no insider…
Published · Jun 25, 2026 BDI 78 ELEVATED Score sealed after pricing Point-in-time inputs unavailable · upper boundFCBM FCBM · trading · ORBIT · Regional Banks First Carolina Financial Services, Inc.A profitable Southeast community bank with $3.4 billion in total assets and a national payments engine, pricing a clean all-primary NYSE…
Published · Jun 16, 2026 BDI 44 SUBDUED Computed from the record Point-in-time inputs unavailable · upper boundWHK WHK · trading · ORBIT · Oil & Gas Minerals & Royalties WhiteHawk Minerals Corp.WhiteHawk Income / Minerals (WHK) NYSE IPO: largest pure-play U.S. natural-gas mineral & royalty portfolio, Marcellus + Haynesville…
Published · May 30, 2026 BDI 65 ACTIVE Computed from the record Point-in-time inputs unavailable · upper boundSSMR SSMR · trading · ORBIT · Silver Mining Sunshine Silver Mining & Refining CoA filing-level read on Sunshine Silver Mining & Refining's NYSE IPO: a 100% primary ~$248M raise priced at the $13.50 floor to fund a…
Published · May 29, 2026 BDI 50 ACTIVE Computed from the record Point-in-time inputs unavailable · upper boundQNT QNT · trading · ORBIT · Quantum Computing Quantinuum Inc.A filing-level read on Quantinuum's ~$1.68B Nasdaq IPO, priced at $60 above its $53–$55 range: a 100% primary raise, an Up-C structure…
Published · May 29, 2026 BDI 82 ELEVATED Computed from the record Point-in-time inputs unavailable · upper boundAADX AADX · trading · ORBIT · Aerospace & Defense Applied Aerospace & Defense, Inc.Applied Aerospace & Defense (AADX) NYSE IPO: a 100% primary, $604M deleveraging raise. Verified S-1/A financials, 10-bank syndicate…
Published · May 29, 2026 BDI 61 ACTIVE Computed from the record Point-in-time inputs unavailable · upper boundINIO INIO · trading · ORBIT · Power & Energy Equipment INNIO N.V.INNIO (INIO) lists on Nasdaq in a $2.43B secondary by Advent International. Verified S-1 financials, 16-bank syndicate, data-center…
Published · May 28, 2026 BDI 66 ACTIVE Computed from the record Point-in-time inputs unavailable · upper boundSPCX SPCX · trading · ORBIT · Space Exploration Technologies Space Exploration Technologies Corp.SpaceX priced at $135 and began trading June 12, 2026. Bellipo's Dossier covers the business, founders, syndicate, comps, and top risks…
Published · May 20, 2026 BDI 83 ELEVATED Computed from the record Point-in-time inputs unavailable · upper boundLCLN LCLN · trading · ORBIT · Financial Advisory Lincoln InternationalLincoln International priced its NYSE IPO at $20.00, the top of its range. Inside: BDI 66, FY2025 financials, the Up-C control structure…
Published · May 20, 2026 BDI 73 ACTIVE Computed from the record Point-in-time inputs unavailable · upper boundThe prospectus, underwritten in plain sight. Fourteen cited modules.
Each Dossier is a sell-side-grade read of the registration statement — every exhibit, footnote, and risk factor — condensed into one issuer file.
01The full S-1 worked end-to-end — business, financials, growth quality, capitalization, comparable transactions. Fourteen modules, each footnoted to the filing.
02No AI drafts. No templated boilerplate. No recycled press releases. Every claim traces to a numbered page in the prospectus.
03Sell-side rigor, written for an operator — not a lawyer. Risks ranked by what moves a tape, not what counsel required disclosed.
04Re-underwritten as the deal moves through RADAR, READY, PING, STRIKE, ORBIT — re-scored on every range revision, roadshow read, and allocation signal.
We respect the firms that built that market — the work is rigorous and their product is excellent. We're building a different one, for a different audience.
Elsewhere · For institutions ~$39,300/yearRenaissance Capital IPO Intelligence — base annual rate for up to six users. The institutional standard for pre-IPO research.
At Bellipo · For everyone else $0/foreverEvery Bellipo Dossier — the full S-1 deep dive, underwriter card, comparables, and risk ranking — open to anyone with a browser. No paywall, no card on file.
Pricing verified from the publicly listed 2026 rate card. Renaissance also operates IPO Pro ($119/mo) for individuals. We're building the free tier the category never had.
“We don't charge for the homework. Pro sells the live alerts, the BDI signals, the lockup math, the data exports — the things a serious investor uses in real time. The Dossiers stay open, because understanding an IPO before you tap Buy shouldn't be a five-figure subscription.”— Isam, founder · Bellipo
One email per Dossier. No promos, no digests, no upsell. Unsubscribe in one click.
Read the SpaceX DossierGet the next one